Planned Parenthood of Greater Ohio is launching a new telehealth program for medication-induced abortions, a shift that could reshape how thousands of Ohioans — especially those in rural communities — access reproductive care. The move immediately collides with a Republican-backed proposal at the Statehouse that seeks to sharply limit the use of telemedicine for abortion drugs.
New telehealth option for abortion pills
Planned Parenthood of Greater Ohio has rolled out statewide telehealth medication abortion services, allowing eligible patients to consult with clinicians remotely and, if appropriate, obtain prescriptions for abortion-inducing drugs without traveling to a clinic for every step of care. The organization says the expansion is designed to reach patients who struggle with transportation, inflexible work schedules, or childcare, barriers that are especially acute in rural parts of the state.
Medication-induced abortions, typically involving a combination of mifepristone and misoprostol, are already the most common method of abortion in Ohio, with more than 10,000 such procedures reported in 2024. Telehealth visits would allow patients to complete required counseling and screening online, with in-person testing or exams ordered when clinically necessary, a model reproductive-rights advocates argue is safe and widely used in other states.
GOP lawmakers push in-person requirement
The telehealth expansion arrives as Republican lawmakers advance House Bill 324, branded the “Patient Protection Act,” which would require in-person evaluations before prescribing a range of what the bill calls “high-risk” medications, including abortion drugs. The measure would bar prescribers from using telehealth alone for drugs that have at least a 5% risk of severe adverse effects and would also prohibit mail-order delivery of those medications.
Though HB 324 does not name abortion medications explicitly, supporters have repeatedly cited abortion pills in hearings and statements, framing the bill as a way to prevent complications they say are more likely when care is delivered remotely. If enacted, the legislation could effectively shut down telehealth-only pathways for medication abortion by forcing patients to travel for in-person visits before receiving prescriptions.
Legal backdrop after Ohio’s abortion amendment
Ohio voters approved a constitutional amendment in 2023 protecting access to abortion and other reproductive health care, prompting courts to block several earlier restrictions, including a six-week abortion ban and some in-person counseling and waiting-period rules. A separate 2021 law that banned telemedicine for medication abortion, Senate Bill 260, remains the subject of ongoing litigation, with advocates arguing it violates the new constitutional protections by imposing unnecessary burdens on patients and providers.
Opponents of HB 324, including physician groups and reproductive-rights organizations, say the new bill is a backdoor attempt to limit abortion by placing abortion drugs on the state’s “high-risk” list and cutting off telehealth access despite evidence the medications are safe and effective when prescribed remotely. In testimony, doctors have warned that the proposal could sweep in other essential medications and reduce access in rural areas where telehealth has become a critical lifeline.
Access for rural patients at stake
Planned Parenthood and other abortion-rights advocates argue that telehealth for medication abortion is particularly important for patients who live far from clinics or lack reliable transportation. They say virtual visits can shorten wait times and reduce costs tied to gas, lodging, childcare, and missed work — delays that can push abortions later into pregnancy or prevent patients from accessing care at all.
Supporters of HB 324 counter that requiring in-person visits ensures better oversight and follow-up for patients using drugs that can carry serious risks, contending telehealth alone may miss warning signs of complications. The clash sets up a likely legal and political test of how far Ohio can go in regulating telemedicine for abortion in the wake of voters’ decision to enshrine reproductive rights in the state constitution.
Key elements of the policy clash
| Issue | Telehealth expansion (PPGO) | House Bill 324 proposal |
|---|---|---|
| Mode of care | Remote consultations for medication abortion via telehealth. | Requires in-person evaluation for designated “high-risk” drugs. |
| Target population | Patients facing travel, work, or childcare barriers, especially rural. | All patients seeking certain high-risk medications, including abortion drugs. |
| Effect on abortion access | Expands access and may reduce delays and costs. | Likely restricts telehealth abortions, increasing travel and appointments. |
| Abortion medication status | Treated as suitable for supervised telehealth prescribing. | Expected to be placed on high-risk list, triggering in-person rule. |
| Legal context | Operates under 2023 reproductive-rights amendment and ongoing suits. |
Could face court challenges as inconsistent with that amendment.
|